Apple Watch Risks US Import Ban After Biden Administration Upholds Patent Ruling
The Biden administration has declined to overrule a U.S. International Trade Commission decision that the Apple Watch infringes patents from medical device company AliveCor, potentially paving the way for an import ban on Apple's smartwatch depending on how the appeals process pans out.
California-based AliveCor said in a statement that it was informed the Biden administration would not overrule a December decision from the ITC that found the Apple Watch infringed AliveCor health monitoring patents related to electrocardiogram technology. From AliveCor's press release:
"We applaud President Biden for upholding the ITC's ruling and holding Apple accountable for infringing the patents that underpin our industry-leading ECG technology," said Priya Abani, CEO of AliveCor. "This decision goes beyond AliveCor and sends a clear message to innovators that the U.S. will protect patents to build and scale new technologies that benefit consumers."
In the December ruling, the ITC recommended a limited exclusion order and a cease-and-desist order for Apple Watch models with ECG features. Were it to be enforced, Apple would no longer be able to import new Apple Watch models that support the ECG app. Apple plans to appeal the ITC's decision in a federal courthouse.
While the ITC decision could end up in an Apple Watch ban, the US Patent and Trademark Office in December also invalidated some of AliveCor's patents, which the medical tech company says it will appeal. At the time, Apple said the ITC's decision confirms that the patents AliveCor asserted in the ITC against Apple cannot be infringed.
AliveCor and Apple are embroiled in several legal battles, as AliveCor has also filed an antitrust lawsuit against Apple and Apple has sued AliveCor for patent infringement. Apple is also battling a patent infringement case brought by medical technology company Masimo, which asserts Apple Watch models that use light sensors to measure blood oxygen levels infringe its pulse oximeter patents.
Popular Stories
Last year, Apple launched CarPlay Ultra, the long-awaited next-generation version of its CarPlay software system for vehicles. Nearly nine months later, CarPlay Ultra is still limited to Aston Martin's latest luxury vehicles, but that should change fairly soon.
In May 2025, Apple said many other vehicle brands planned to offer CarPlay Ultra, including Hyundai, Kia, and Genesis.
In his Powe...
The calendar has turned to February, and a new report indicates that Apple's next product launch is "imminent," in the form of new MacBook Pro models.
"All signs point to an imminent launch of next-generation MacBook Pros that retain the current form factor but deliver faster chips," Bloomberg's Mark Gurman said on Sunday. "I'm told the new models — code-named J714 and J716 — are slated...
We are still waiting for the iOS 26.3 Release Candidate to come out, so the first iOS 26.4 beta is likely still at least a week or two away. Following beta testing, iOS 26.4 will likely be released to the general public in March or April.
Below, we have recapped known or rumored iOS 26.3 and iOS 26.4 features so far.
iOS 26.3
iPhone to Android Transfer Tool
iOS 26.3 makes it easier...
Apple is planning to launch new MacBook Pro models with M5 Pro and M5 Max chips alongside macOS 26.3, according to Bloomberg's Mark Gurman.
"Apple's faster MacBook Pros are planned for the macOS 26.3 release cycle," wrote Gurman, in his Power On newsletter today.
"I'm told the new models — code-named J714 and J716 — are slated for the macOS 26.3 software cycle, which runs from...
In 2022, Apple introduced a new Apple Home architecture that is "more reliable and efficient," and the deadline to upgrade and avoid issues is fast approaching.
In an email this week, Apple gave customers a final reminder to upgrade their Home app by February 10, 2026. Apple says users who do not upgrade may experience issues with accessories and automations, or lose access to their smart...
